Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia

被引：3
|
作者：
Genest, Dominique S. [1 ]
Pelletier, Karyne [1 ]
Dallaire, Gabriel [2 ]
Faucher, Genevieve [3 ]
Troyanov, Stephan [1 ]
机构：
[1] Hop Sacre Coeur Montreal, Div Nephrol, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada
[2] Hop Sacre Coeur Montreal, Dept Pharm, Montreal, PQ, Canada
[3] Hotel Dieu St Jerome, Div Hematol, St Jerome, PQ, Canada
来源：
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 03期
关键词：
D O I：
10.1016/j.ekir.2021.01.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：865 / 866
页数：2
相关论文
共 50 条
  • [11] Tolerance and efficacy of rituximab for type 11 mixed cryoglobulinemia (MC)
    Gallien, S.
    Le Guern, V.
    Cohen, P.
    Marien, M.
    Mouthon, L.
    Guillevin, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 373 - 373
  • [12] Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients
    Basse, G.
    Ribes, D.
    Kamar, N.
    Mehrenberger, M.
    Sallusto, F.
    Esposito, L.
    Guitard, J.
    Lavayssiere, L.
    Oksman, F.
    Durand, D.
    Rostaing, L.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2308 - 2310
  • [13] Treatment of glomerulonephritis in type II mixed cryoglobulinemia with rituximab.
    Quartuccio, L
    Soardo, G
    Romano, G
    Sacco, S
    Esposito, W
    De Marchi, G
    De Vita, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S235 - S235
  • [14] Efficacy and safety of rituximab in HCV-related mixed cryoglobulinemia
    Marchi, F.
    Della Rossa, A.
    Tavoni, A.
    Baldini, C.
    d'Ascanio, A.
    Bombardieri, S.
    Migliorini, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A45 - A45
  • [15] Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia
    Quartuccio, L.
    Petrarca, A.
    Mansutti, E.
    Pieroni, S.
    Calcabrini, L.
    Avellini, C.
    Zignego, A. L.
    De Vita, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (01) : S84 - S87
  • [16] Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab
    Niklas T. Baerlecken
    Reinhold E. Schmidt
    Clinical Rheumatology, 2013, 32 : 19 - 20
  • [17] Lymphoproliferative disease-related mixed cryoglobulinemia treated with rituximab and prednisolone
    Shimamura, Yoshinosuke
    Takizawa, Hideki
    Ogawa, Yayoi
    Sakai, Hajime
    Ryu, Akane
    Moniwa, Norihito
    Hasegawa, Koichi
    Ura, Nobuyuki
    CEN CASE REPORTS, 2015, 4 (01): : 6 - 13
  • [18] Efficacy and safety of rituximab treatment in Type II mixed cryoglobulinemia.
    De Vita, S
    Zaja, F
    Sacco, S
    Michelutti, A
    De Marchi, G
    Mazzaro, C
    Fanin, R
    Ferraccioli, G
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S206 - S206
  • [19] Improvement in Psoriasis During Rituximab Therapy for Mixed Cryoglobulinemia Type II
    Moberg, Philip
    Charles, Julia F.
    Respicio, Guada
    Venna, Suraj S.
    Rooney, Terence
    CUTIS, 2010, 86 (03): : 133 - 135
  • [20] The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia
    Goncalves Rego, Thiago Carlos
    Massumoto, Celso Mitsushi
    Batista, Rodrigo Siqueira
    de Moura, Larissa Hanauer
    Costa Soares, Lygia Maria
    Gomes, Andreia Patricia
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (01): : 174 - 175
12345